Medical education provider CME Outfitters is launching a live, on-demand event called “Novel Treatment of Inflammatory Bowel Disease Informed by Science and Patient Choice,” on March 11, 2015 at 12:00pm ET. The program will include an hour of interactive debate with medical experts about the evolution of inflammatory bowel diseases (IBD).
Attending this live event are academic specialists Russell D. Cohen, MD, FACG, AGAF, Gary L. Lichtenstein, MD, FACP, FACG, AGAF, and Miguel Regueiro, MD, AGAF, FACG, FACP, who have been invited to provide information on choosing the best therapies, managing side effects, and personalizing approaches to IBD clinical care.
The 90-minute program will available online, with a live panel discussion featuring the latest international research updates on IBD. It is designed to allow both clinicians and patients to participate in real time, with 30 minutes of the event being dedicated to providing participants with the opportunity to ask additional questions, talk to faculty members and peers, and sound off on their personal obstacles via phone call, through the Q&A widget on the web interface, email, or Twitter.
“We are so excited to share the Live and On Demand learning experience with gastroenterologists and clinical care providers in IBD,” said Jan Perez from CCMEP, a CME Outfitters Managing Partner. “Not only is there an very apparent need to educate clinicians who manage patients with moderate-to-severe IBD about the immunopathophysiology of IBD and the latest available options to individualize IBD treatment, but we’re doing it in a way that allows clinical care providers to learn from some of the best in the field, and in a format that encourages a real faculty-to-learner collaboration where clinicians can ask about their toughest clinical cases and questions in up to six different ways — web interface, email, phone, Twitter, fax, or live on air.”
The participants of the program are expected to gain knowledge about the pathophysiology of IBD, the importance of lymphocyte trafficking in treatment choices, currently available treatment paradigms and options, and anti-TNF agents in moderate-to-severe IBD patients. Other topics to be addressed include the implementation of novel treatment plans in light of IBD’s immunopathogenesis and disease mechanism. Registration is required and can be accessed here.
Last December, CMEO also partnered with USF Health, to host an interactive Continuing Medical Education (CME) symposium that took place during the 2014 Advances in Inflammatory Bowel Diseases Crohn’s & Colitis Foundation’s Clinical & Research Conference. The “A Patient-Centered Approach to Achieve Remission in Ulcerative Colitis“ was led by the two esteemed gastroenterologists, Maria T. Abreu and Raymond K. Cross, and was designed to help clinicians achieve new practice challenges.